The historic rise of Viagra has firmly established as a benchmark of pharmaceutical success, but its position within the broader industry now triggers questions about potential yields . Copycat versions are diminishing patent protection , prompting anxieties that supporting companies heavily reliant to Viagra's previous influence could be a dangero